Ronald L. Gibson, Jr., M.D., Ph.D.

CURRICULUM VITAE

Ronald L. Gibson, Jr., M.D., Ph.D. March 2009

1. Personal Data

Born:September 2, 1954

Seattle, Washington

Married:Maren Holmquist Gibson on June 5, 1976

Children:Kali Alexandra Gibson (1/17/1984)

Bryn Maren Gibson (1/7/1987)

2. Education

Undergraduate:1972-75University of Washington, Seattle, Washington - Major field of Biology, B.S.

Graduate:1976-82Washington University Schools of Medicine and Arts & Sciences, St. Louis, Missouri - M.D. and Ph.D.

Doctoral Thesis: The role of oligosaccharide chains in the maturation and physical properties of the G protein of vesicular stomatitis virus

3. Postgraduate Training

Internship:1982-83 Pediatrics, University of WashingtonSchool of Medicine, Seattle, Washington

Residency:1983-85 Pediatrics, University of WashingtonSchool of Medicine, Seattle, Washington

1985 Assistant Chief Pediatric Resident, University of

WashingtonSchool of Medicine, Seattle, Washington

Fellowship:1985-88Pediatric Pulmonology, Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington

4. Faculty Positions Held

1988-1994Assistant Professor, Department of Pediatrics, University of WashingtonSchool of Medicine, Seattle, Washington

1991-1997Research Affiliate, Child Development and Mental RetardationCenter, University of Washington, Seattle, Washington

1994-2003Associate Professor, Department of Pediatrics, University of WashingtonSchool of Medicine, Seattle, Washington

2003-presentProfessor, Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington

5. Hospital Positions Held

1988-presentAttending Physician, Seattle Children's Hospital, Seattle, Washington

1988-presentConsultant, University of Washington Medical Center, Seattle, Washington

1994-99Consultant, SwedishHospital & MedicalCenter Special Care Nursery, Seattle, Washington

6. Honors and Awards

1975 B.S. summa cum laude in Biology, University of Washington

1975 Phi Beta Kappa, University of Washington, Seattle, Washington

1976-82 Medical Scientist Training Grant from the National Institutes of Health, Washington University School of Medicine, St. Louis, Missouri

1977 Richard S. Brookings Medical Prize, WashingtonUniversitySchool of Medicine, St. Louis, Missouri

1982 Alexander Berg Prize in Microbiology, WashingtonUniversitySchool of Medicine, St. Louis, Missouri

1982 Alpha Omega Alpha (AOA), WashingtonUniversitySchool of Medicine, St. Louis, Missouri

1991 Outstanding Teacher Award, University of WashingtonSchool of Medicine, Pediatric Residency Training Program

1997Stanley Stamm Role Model Award in Medicine (for conscientious teaching and patient care), University of Washington School of Medicine, Pediatric Residency Training Program

1997Society for Pediatric Research, Elected Member

1999Outstanding Teacher Award, University of WashingtonSchool of Medicine, Pediatric Residency Training Program

2000Family Choice Award from the Parent Advisory Council at Children’s Hospital & Regional Medical Center (CHRMC), Seattle, WA

2000Voted one of Seattle’s Top Doctors per Seattle Magazine poll of peers

2001Nominee, Family Choice Award from Parent Advisory Council at CHRMC

2002 Nominee, Family Choice Award from Parent Advisory Council at CHRMC

2004Outstanding Teacher Award, University of WashingtonSchool of Medicine, Pediatric Residency Training Program

2005Voted one of Seattle’s Top Doctors per Seattle Magazine poll of peers

2005Nominee, Family Choice Award from Family Advisory Council at CHRMC

2005Selected to the Best Doctors in America

2006Voted one of Seattle’s Top Doctors per Seattle Magazine poll of peers

2007Voted one of Seattle’s Top Doctors per Seattle Magazine poll of peers

2007-08Selected to Best Doctors in America

2008Mentoring Award from the University of Washington School of Medicine, Department of Pediatrics (recognizes outstanding mentoring of junior faculty)

2008Voted one of Seattle’s Top Doctors per Seattle Magazine poll of peers

Grants/Research Awards

1985-1990National Institutes of Health, Program Project (PI, W.A. Hodson):

Neonatal Pulmonary Circulation: Co-Investigator (R. Gibson)

1987 Research Training Fellowship, American Lung Association, 1987-88

1987 Research Grant, American Lung Association: The Specificity and

Bacterial Stimulus of Pulmonary Hypertension in Neonatal Sepsis

1988 Research Training Fellowship, American Lung Association, 1988-89

1988-91 RJR Nabisco Research Scholar Award: Bacterial-Host Cell

Interactions that Stimulate Proinflammatory Mediators in

Neonatal Group B Streptococcal Sepsis

1990-95Maternal Child Health, Pediatric Pulmonary Center Training Grant

(P.I.: G. Redding, Co-I: R. Gibson)

1991-93 Research Grant, WashingtonTechnologyCenter: The Role of

Pulmonary Microvascular Endothelial Cell Response in Lung Disease

1991-94Edward Livingston Trudeau Scholar Award, American Lung

Association: Group B Streptococcus Endothelial Cell Interactions

1993-98Co-PIs (B. Ramsey, R. Gibson)/Mentors of Leroy Matthews

Physician Scientist Award

1995-2000Maternal Child Health, Pediatric Pulmonary Center Training Grant

(P.I.: G. Redding, Co-I: R. Gibson)

1996-97Cystic Fibrosis Foundation Grant

Gene Therapy in the Developing Airways of Mice

1996-97Cystic Fibrosis-Research Development Program Pilot Grant

1998-Cystic Fibrosis Clinical CareCenter Grant (PI, R. Gibson)

1998-2003Cystic Fibrosis Foundation Therapeutics Development Center

(Co-PIs R. Gibson/Moira Aitken)

1999-Director of the Clinical Core, CFF- Research Development Program

2000-2005Maternal Child Health, Pediatric Pulmonary Center Training Grant

(P.I.: G. Redding, Co-I: R. Gibson)

1999-2002Food and Drug Administration Orphan Product Development Grant

TOBI in Young Children with Cystic Fibrosis (Co-PI, R. Gibson)

2000-2005National Institutes of Health: Inhaled Tobramycin in Young Cystic Fibrosis Patients (#RO1 DK57755-01, PI-B. Ramsey, Co-PI R. Gibson)

2003-2008Cystic Fibrosis Foundation Therapeutics Development Center (Co-PIs R. Gibson/Moira Aitken, $500,000)

2003-2007Cystic Fibrosis Foundation Therapeutics: Standard vs. Biofilm

Susceptibility Testing in CF (PI: J. Burns/Moskowitz, Co-I: R. Gibson)

2004-2009Cystic Fibrosis Foundation Therapeutics: Early Pseudomonas

Infection Control (EPIC)-Observational Study

(PIs: M. Rosenfeld, R. Gibson)

2007-2009Cystic Fibrosis Foundation Therapeutics: Early Pseudomonas Infection Control (EPIC)-Observational Study- DNA Collection

Amendment (PI: R. Gibson)

2009-2014Cystic Fibrosis Foundation Therapeutics: Early Pseudomonas

Infection Control (EPIC)-Observational Study-Phase II

(PIs: M. Rosenfeld, R. Gibson)

2009-2014Cystic Fibrosis Foundation Translational TherapeuticsDevelopmentCenter

(Co-PIs: R Gibson, M. Aitken).

7. Board Certification

1982National Board of Medical Examiners

1988-Board Certified in Pediatrics (#36845)

1992-1999Board Certified in Pediatric Pulmonology (#303)

2000-2006Re-certified in Pediatric Pulmonology (PRCP-MS)

2007-2013Re-certified in Pediatric Pulmonology (PRCP-MS)

8. Current License to Practice

1983-presentWashington (# MD00021155)

9. Professional Organizations

National:

1986-88 AmericanAcademy of Pediatrics

1986-American Thoracic Society

1992-Pediatric Pulmonary Training Directors Association

1994-1998American Society for Microbiology

1997-Society for Pediatric Research

Local:

1989-Washington Thoracic Society

1990-Western Society for Pediatric Research

1990-Washington Chapter, AmericanAcademy of Pediatrics

10. Teaching Responsibilities
Medical Students- Interact with 2-3 medical students each week of inpatient service with daily case-based teaching in subspecialty rounds, or in weekly Chest/CF Clinic at CHRMC

Residents- Interact closely with 6 residents on the Pulmonary Team and 1-2 additional residents on the pulmonary elective for each week of subspecialty attending (10-12 weeks the past two years). These interactions include cased-based teaching at the bedside and in outpatient clinics, and 1-2 mini-lectures per week of attending.

Pediatric Pulmonology Fellows- co-Director of fellowship program with active role in recruitment, curriculum development, evaluation of trainees, and career counseling; Goal of one first-year fellow each year.

Graduates of our Pediatric Pulmonology Program (1992-2005):

Timothy D. Murphy, M.D.Associate Professor, Univ. of Pittsburgh Margaret Rosenfeld, M.D.,M.P.H. Associate Professor, Univ. of Washington

John P. Osborn, M.D. Clinical Assoc. Professor, Univ. of Virginia

Sonia K. Budhecha, M.D.Assistant Professor, Univ. of Nevada, Reno

Toby S. Lewis, M.D., M.P.H.Assistant Professor, University of Michigan

Samuel M. Moskowitz, M.D.Assistant Professor, Univ. of Washington

Jason S. Debley, M.D., M. P. H.Assistant Professor, Univ. of Washington

Martha McKinney, M.D., M.P.H.Asst. Prof., Queens Univ., Kingston, Ontario Lucas R. Hoffman, M.D., Ph.D. Assistant Professor, Univ. of Washington

Danny Hsia, MDOakland Children’s Hospital

DB Sanders, MD, MPHAsst. Prof, University of Wisconsin, Madison

11. Editorial Responsibilities: no editorial boards

12. Special National and Regional Committees/Activities

1992-Member, Pediatric Pulmonary Training Directors Association (PEPTDA)

1993Member, Committee to Review the Uniformed Services Pediatric Seminar Scientific Awards Competition for the Andrew Margileth Award

1995-Coordinator/Moderator for Regional, Quarterly CF Clinical Conferences including the University of Washington Adult Program, Spokane Affiliate Program, Tacoma Affiliate Program, Anchorage Affiliate Program, and Invitees from the University of Oregon and British Columbia

1997Site Visit to Affiliate CF Program in Spokane, WA

1998-2003Member, Steering Committee for the Cystic Fibrosis Therapeutic DevelopmentCenter Network

1998-Member, Pediatric Planning Committee for the Cystic Fibrosis Foundation (CFF) Therapeutic DevelopmentCenter Network (TDN)

1998Member, PEPTDA Workforce and Recruitment Subcommittee

1998Chairperson, Committee to develop Standard Operating Procedure for Spirometry within the Cystic Fibrosis Foundation Therapeutic Development Network (TDN)

1998Member, Committee to develop a Standard Operating Procedure for Nasal Potential Difference Measurements within the CFF TDN

1997Member, Data Safety Monitoring Committee for Intrabiotics-367 Multicenter Phase I Study

1998Speaker/Panelist at Roundtable Discussion on Guidelines for Assessing Affiliate CF Centers at the 1998 North American CF Foundation Meeting

1998Member, Committee to Review the Uniformed Services Pediatric Seminar Scientific Awards Competition for the Andrew Margileth Award

1999Site Visit to Affiliate CF Program in Anchorage, Alaska

1998Visiting Professor, University of California, San Diego, including Grand Rounds at Children’s Hospital, San Diego entitled “Cystic Fibrosis: Pathophysiology and Update on Treatment”

1999Invited Speaker for Post-Graduate Symposium on Aerosolized Antibiotics at the American Thoracic Society International Meeting

1999Roundtable Discussion Leader on Aerosolized Antibiotics in Cystic Fibrosis at the 1999 International North American Cystic Fibrosis Foundation Meeting

2000Site Visit to Affiliate CF Program in Spokane, WA

2000Chairperson, Committee on Early Interventions in Cystic Fibrosis, Northwest Cystic Fibrosis Consortium, Epidemiologic Study in Cystic Fibrosis (Genentech)

2000Invited to Cystic Fibrosis Foundation Williamsburg Conference

2000-Member, Cystic Fibrosis Foundation (CFF) Clinical Research Committee for National Review of Research Grants

2001Invited Speaker at American Thoracic Conference, “Impact of Early Antibiotic Treatment in Young Children with Cystic Fibrosis”

2001-Member, CFF-TDN Committee to Establish Quality Control Standards for Pulmonary Function Testing

2001Member, CFF-TDN Task Force for Re-Structuring of the Therapeutics Development Network

2002Member, Nominating Committee for Pediatric Pulmonary Training Directors Association Officers

2002-04Member, Steering Committee on Joint Project between the CFF and Proteome Systems (Australia)

2002Invited Speaker at the 2002 European CF Conference in Genoa, Italy, “Tobramycin Solution for Inhalation in Young Children with CF: Eradication of Lower Airway Pseudomonas”

2002-Member, Protocol Development Committee for the CF Therapeutics Development Network

2003Invited Speaker, “Pseudomonas Summit”, Cystic Fibrosis Foundation, Bethesda, MD

2004-2007Member, Steering Committee for the Cystic Fibrosis Therapeutic DevelopmentCenter Network

2004Invited Speaker at the 2004 European CF Conference in Birmingham, England

“Early Intervention Strategies in CF Lung Disease”

2004Member, National Committee to Develop Educational Slide Set on Early Intervention in Cystic Fibrosis

2004-Member, International CF Foundation Antimicrobial Task Force for Drug Development

2004-Member, Steering Committee, Early Pseudomonal Infection Control Study

2004-Chair, Publications & Presentations Committee, Early Pseudomonal Infection Control Study

2006Faculty for CF Foundation-sponsored national training course on GCP Clinical

Researchat 2006 North American CF Conference

2007-2008Selected Site in Cystic Fibrosis (CF) Foundation Leadership & Learning Collaborative V-National Continuous Quality Improvement Project to Improve Pulmonary Outcomes in CF

2007Co-Chairperson, Pseudomonas Workshop, Williamsburg Cystic Fibrosis Conference

2008Workshop Leader, International Consensus Conference on Pseudomonas Serology in CF, Bethesda, MD

13. Special Local Responsibilities/Committees

1988-University of Washington Pediatric Housestaff Selection-interviewer

1988-1990University of Washington Pediatric Intern Selection Committee

1989WAMI Visiting Professor, Sacred HeartMedicalCenter, Spokane, Washington

1989WAMI Visiting Professor, Yakima Pediatric Associates, Yakima, Washington

1990-2005Associate Director, Pediatric Pulmonary Center Training Grant (MCH #539167)

1990WAMI Visiting Professor, Yakima Pediatric Associates, Yakima, Washington

1991-2001Pharmacy and Therapeutics Committee, Children's Hospital & MedicalCenter, Seattle, Washington

1991Pediatric Grand Rounds at Children’s Hospital & RegionalMedicalCenter: Update on Bronchopulmonary Dysplasia

1991WAMI Visiting Professor, Yakima Pediatric Associates, Yakima, Washington

1992-Co-Director, Pediatric Pulmonary Fellowship Program, University of WashingtonSchool of Medicine, Seattle, Washington

1992-Co-Director, Pediatric Pulmonology Weekly Journal Club, Children's Hospital & RegionalMedicalCenter, Seattle, Washington

1992WAMI Visiting Professor, Yakima Pediatric Associates, Yakima, Washington

1993-5PMD Representative to Virginia Mason, South, Children's Hospital & MedicalCenter, Seattle, Washington

1993WAMI Visiting Professor, Yakima Pediatric Associates, Yakima, Washington

1994Chairman, Asthma Clinical Care Pathway, Children's Hospital & MedicalCenter, Seattle, Washington

1994WAMI Visiting Professor, Yakima Pediatric Associates, Yakima, Washington

1994-95POD C Outpatient Clinics Workgroup, Committee Member, Children's Hospital & Medical Center, Seattle, Washington

1995Pediatric Grand Rounds at Children’s Hospital & RegionalMedicalCenter: Review of Asthma Clinical Pathway

1995Speaker at Parent’s Day Educational Conference on Cystic Fibrosis

1995WAMI Visiting Professor, Yakima Pediatric Associates, Yakima, Washington and Toppenish Farm Workers Clinic/Providence Hospital, Toppenish, Washington

1996Chairman, Asthma Clinical Care Pathway Revision I, Children’s Hospital & Medical Center, Seattle, WA

1996Member, Laboratory Space Committee for the Department of Pediatrics, University of Washington School of Medicine, Seattle, WA

1996WAMI Visiting Professor, Yakima Pediatric Associates, Yakima, Washington and Toppenish Farm Workers Clinic/Providence Hospital, Toppenish, Washington

1996-1998Associate Director of the Cystic Fibrosis Center, Children’s Hospital & Medical Center, Seattle, Washington

1996-Member, Grand Rounds Steering Committee, Children’s Hospital & MedicalCenter, Seattle, WA

1996Member, Cardiovascular Surgery Quality Assurance Committee, Children’s Hospital & Medical Center, Seattle, WA

1997Asthma Managed Care Focus Group, Children’s Hospital and RegionalMedicalCenter, Seattle, WA

1999Chairperson, Asthma Clinical Pathway Revision II, Children’s Hospital & RegionalMedicalCenter, Seattle, WA

1997Member of Internal Review Committee for Child & Adolescent Psychiatry Training Program, University of Washington/CHRMC, Seattle, WA

1998Speaker at Parent’s Day Educational Conference on Cystic Fibrosis

1998Team Member for Care Coordination Pilot with Asthma Patients, CHRMC, Seattle, WA

1998Team Member for the Cystic Fibrosis Managed Care Readiness Project, CHRMC, Seattle, WA

1998Acting Director of the Cystic Fibrosis Center, CHRMC, Seattle, WA

1998-Center Director, Pediatric Program Director for the CysticFibrosisCenter, University of Washington, Children’s Hospital & RegionalMedicalCenter, Seattle, WA

1998-Director/Moderator of CF Center Quarterly Regional Conferences on Clinical Care- includes Pediatric CF Center at CHRMC, Adult CF Program at UWMC, Affiliate CF Programs at MaryBridge in Tacoma, WA, DeaconessHospital in Spokane, WA, and invitees from Kaiser in Portland, OR and CF Centers in Victoria and Vancouver, BC, Canada.

1998Chairperson, Cystic Fibrosis Clinical Pathway Revision Committee, CHRMC, Seattle, WA

1998-Local Spokesperson for Great Strides Fundraiser for Cystic Fibrosis

1999 Speaker at Parent’s Day Educational Conference on Cystic Fibrosis

1999Member, Asthma Clinical Pathway Revision Committee, CHRMC, Seattle, WA

1999CHRMC Quarterly Curbstone Consult: Chronic Cough (Editor, Dr. S. Dassel)

1999Chairperson, CHRMC Pharmacy & Therapeutics Subcommittee for Palivizumab

(Synagis) Guidelines

1999Speaker at 19th Annual F. Richard Dion Pediatric Update, Seattle, WA: Asthma

2000Speaker at Parent’s Day Educational Conference on Cystic Fibrosis

2000WWAMI Visiting Professor, Peninsula Children’s Clinic, Port Angeles, WA

2000CHRMC Quarterly Curbstone Consult: Asthma Pathway (Editor: Dr. S. Dassel)

2001Speaker at Parent Day Educational Conference on Cystic Fibrosis

2002Site Visit to Affiliate CF Center, Anchorage, Alaska

2002Invited Speaker at Puget Sound Allergy & Asthma Society Meeting: Update on the Diagnosis and Management of CF

2002Speaker at CF Regional Quarterly Conference: Macrolides and CF

2003Site Visit to Affiliate CF Center, Spokane, Washington

2003Speaker, CF Quarterly Regional Conference: Early Intervention for Pseudomonas in Children with CF

2004Member, Inpatient Medicine Project Subcommittee on Education

2004WWAMI Visiting Professor, Yakima Pediatric Associates, Yakima, WA and Toppenish Farm Workers Clinic/Providence Hospital, Toppenish, WA

2004Member, Cystic Fibrosis Research Faculty Search Committee, Department of Pediatrics/CHRMC (Chair: B. Ramsey)

2004Member, Neonatal Research Faculty Search Committee (Chair: D. Woodrum), Department of Pediatrics, University of WashingtonSchool of Medicine

2004Member, Institutional Review Board Forms Committee, CHRMC, Seattle, WA

2005Speaker at Parent’s Day Educational Conference on Cystic Fibrosis

2005Speaker at CF Quarterly Regional CF Conference: Hypertonic Saline in CF

2005-Director, Pediatric Pulmonary Fellowship Program, University of Washington School of Medicine, Seattle, Washington

2005-2007Member, Scholarship Oversight Committee for Pediatric Critical Care Fellow, Iain Asplin, MD, PhD

2006-Member, CUMG Physician Education, Billing, and Compliance Committee

2006-Member, Human Subject Protection Program Advisory Committee, CHRMC

2006WWAMI Visiting Professor, Pocatello Children & Adolescent Clinic, Pocatello, ID, and St. Luke’s Regional Medical Center, Boise, ID (3-day trip)

2006Panel Member, R2 Pediatric Retreat on Academic Career Options

2006Scientist/Poster Presenter at CHRMC Centennial Kick-off Research Event

2006-8Ad hoc member, Scholarship Oversight Committee, Danny Hsia, MD

2007Invited Speaker at 7th Annual Madigan Pediatric Update Conference: Update on the Treatment of CF Lung Disease.

2007Speaker at Parent’s Day Educational Conference on Cystic Fibrosis

2007-Member, Steering Committee, Center for Clinical and Translational Research, Seattle Children’s Hospital Research Institute

2007Presentation of the CHRMC Cystic FibrosisCenter Quality Improvement Program to the CHRMC Board

2007-9Ad hoc member, Scholarship Oversight Committee, DB Sanders, MD

2008WWAMI Visiting Professor, Peninsula Children’s Clinic, Port Angeles, WA

2008Participant in Medical Ward Team Configuration Meeting, CHRMC

2008Member, Review Committee for the Center for Clinical and Translational Research Mentored Scientist Program, Seattle Children’s Hospital

2008-Member, Recruitment Subcommittee for the Center for Clinical and Translational Research, Seattle Children’s Hospital

2008Case Presenter at Sconyers/Godfrey Ethics Grand Rounds, CHRMC

2008-Member, Appointments and Promotions Committee, Department of Pediatrics, University of Washington School of Medicine

2009Speaker, CF Parent Education Day

14. Research Funding

Name of Individual: Ronald L. Gibson, MD, PhD

ACTIVE(Renewable annually)

Project Number: C117-04Dates of Current Project: 7/1/08-6/30/09

Principal Investigator: Ronald L. Gibson, MD, PhDPercent Effort: 15%

Source: Cystic Fibrosis FoundationDirect Costs: $230,322

Title of Project: Cystic FibrosisCenter Grant

Major goals this project: Funding for ongoing support of the Cystic Fibrosis Clinical Center.

Name of Individual: Ronald L. Gibson, MD, PhD

ACTIVE

Project Number: GIBSON98Y0Dates of Entire Project: 4/1/09-3/31/14

Principal Investigator: Ronald L. Gibson, MD, PhDPercent Effort: 10%

Source: Cystic Fibrosis FoundationCurrent Direct Costs: $200,000

Title of Project: Translational Therapeutic DevelopmentCenter

Major goals of this project: To develop and conduct Phase I/II clinical trials in cystic fibrosis related research as part of the Cystic Fibrosis Foundation's Therapeutic Development Network.

Name of Individual: Ronald L. Gibson, MD, PhD

Role: Co-Investigator, Director of Clinical Core for Research Development ProgramACTIVE

Project Number: R565 Dates of Project: 10/1/08-9/30/09

Principal Investigator: E. Peter Greenberg, PhDPercent Effort: 5%

Source: Cystic Fibrosis FoundationDirect Costs: $42,000

Title of Project: Molecular Biology of Cystic Fibrosis: Clinical Core

Major goals of this project: To provide a national resource for development of well-designed clinical investigations in patients with CF and to foster collaboration with basic scientists to promote pilot studies by providing patient specimens or clinical data.

Name of Individual: Ronald L. Gibson, MD, PhD

Role: Co-Investigator

Project Number: BURN03A0Dates of Project: 6/1/04-12/31/07

Principal Investigator: Jane Burns, MDPercent Effort: 3%

Source: Cystic Fibrosis FoundationDirect Costs: $228,355

Title of Project: Standard versus Biofilm Susceptibility Testing in Cystic Fibrosis

Major goals of this project: To compare the microbiological efficacy, clinical efficacy, and safety of using standard versus biofilm susceptibility testing of P.aeruginosa sputum isolates to guide antibiotic selection of airway infection in clinically stable patients with CF.

Name of Individual: Ronald L. Gibson, MD, PhD

Role: Co-Principal Investigator

Dates of Project: 4/1/09-3/30/14Percent Effort: 15%

Source: Cystic Fibrosis FoundationDirect Costs: $1,328,747

Title of Project: EPIC Observational Study

Major goals of this project: A large, multicenter, prospective, descriptive study of the risk factors for and outcomes associated with initial acquisition of Pseudomonas aeruginosa as well as outcomes associated with therapy among CF patients 1 to 12 years of age.

GIBSON07K0 (Gibson – PI)9/1/07 – 8/31/09